newsfilter
← Latest News
GlobeNewswire·

LexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared

BEVERLY, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing,